Natural History and Prognosis

[1]  J. Ortonne.  Special Features of Vitiligo , 2008 .

[2]  M. Picardo,et al.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. , 2007, Pigment cell research.

[3]  B. Kumar,et al.  Psoralen–ultraviolet A vs. narrow‐band ultraviolet B phototherapy for the treatment of vitiligo , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  S. Dogra,et al.  Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. , 2004, Journal of the American Academy of Dermatology.

[5]  D. Parsad,et al.  Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo , 2003, Clinical and experimental dermatology.

[6]  D. Thappa,et al.  Clinical predictors of outcome in vitiligo. , 2002, Indian journal of dermatology, venereology and leprology.

[7]  J. Yoo,et al.  Clinical and histopathologic characteristics of trichrome vitiligo. , 2000, Journal of the American Academy of Dermatology.

[8]  W. Westerhof,et al.  Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. , 1999, Archives of dermatology.

[9]  S. Hann,et al.  Clinical characteristics of progressive vitiligo , 1997, International journal of dermatology.

[10]  S. Hann,et al.  Segmental vitiligo: clinical findings in 208 patients. , 1996, Journal of the American Academy of Dermatology.

[11]  A. Alzate,et al.  The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation. , 1995, Journal of the American Academy of Dermatology.

[12]  Y. Gauthier.  The importance of Koebner's phenomenon in the induction of vitiligo vulgaris lesions , 1995 .

[13]  J. Bystryn,et al.  Cytolytic antibodies to melanocytes in vitiligo. , 1993, The Journal of investigative dermatology.

[14]  J. Bystryn,et al.  Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. , 1991, The Journal of investigative dermatology.

[15]  H. Tagami,et al.  Therapeutic success of epidermal grafting in generalized vitiligo is limited by the Koebner phenomenon. , 1990, Journal of the American Academy of Dermatology.

[16]  T. Tango,et al.  Clinical features and course of type A and type B vitiligo , 1988, The British journal of dermatology.

[17]  Y. Mishima,et al.  Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma‐associated vitiligo in relation to steroid effects , 1984, Journal of cutaneous pathology.

[18]  J. Nordlund,et al.  Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. , 1982, The Journal of investigative dermatology.

[19]  M. Koga.  Vitiligo: a new classification and therapy , 1977, The British journal of dermatology.